Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis

被引:13
|
作者
Barba, Maddalena [13 ]
Yang, Li [12 ]
Schuenemann, Holger J. [10 ,11 ,13 ]
Sperati, Francesca [13 ]
Grioni, Sara [9 ]
Stranges, Saverio [8 ]
Westerlind, Kim C. [6 ,7 ]
Blandino, Giovanni [5 ]
Gallucci, Michele [4 ]
Lauria, Rossella [3 ]
Malorni, Luca [2 ,3 ]
Muti, Paola [1 ]
机构
[1] Natl Canc Inst Regina Elena, Sci Direct, Rome, Italy
[2] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA
[3] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Div Med Oncol, Naples, Italy
[4] Natl Canc Inst Regina Elena, Dept Urol, Rome, Italy
[5] Natl Canc Inst Regina Elena, Lab B, Translat Oncogenom Unit, Rome, Italy
[6] Univ Colorado, Div Endocrinol Diabet & Metab, Denver, CO 80202 USA
[7] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[8] Warwick Med Sch, Hlth Sci Res Inst, Coventry, W Midlands, England
[9] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy
[10] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[11] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA
[12] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Environm Agr & Occupat Hlth, Omaha, NE USA
[13] Natl Canc Inst Regina Elena, Dept Epidemiol, Rome, Italy
关键词
BREAST-CANCER; RISK; 16-ALPHA-HYDROXYESTRONE; BIOMARKERS; INDUCTION; TISSUE; MCF-7;
D O I
10.1186/1756-9966-28-135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate prostate cancer (Pca) risk in relation to estrogen metabolism, expressed as urinary 2-hydroxyestrone (2-OHE1), 16 alpha-hydroxyestrone (16 alpha-OHE1) and 2-OHE1 to 16 alpha-OHE1 ratio. Methods: We conducted a case-control study within the Western New York Health Cohort Study (WNYHCS) from 1996 to 2001. From January 2003 through September 2004, we completed the re-call and follow- up of 1092 cohort participants. Cases (n = 26) and controls (n = 110) were matched on age, race and recruitment period according to a 1: 4 ratio. We used the unconditional logistic regression to compute crude and adjusted odds ratios (OR) and 95% confident interval (CI) of Pca in relation to 2-OHE1, 16 alpha-OHE1 and 2-OHE1 to 16 alpha-OHE1 by tertiles of urine concentrations (stored in a biorepository for an average of 4 years). We identified age, race, education and body mass index as covariates. We also conducted a systematic review of the literature which revealed no additional studies, but we pooled the results from this study with those from a previously conducted case-control study using the DerSimonian-Laird random effects method. Results: We observed a non-significant risk reduction in the highest tertile of 2-OHE1 (OR 0.72, 95% CI 0.25-2.10). Conversely, the odds in the highest tertile of 16 alpha-OHE1 showed a non-significant risk increase (OR 1.76 95% CI 0.62-4.98). There was a suggestion of reduced Pca risk for men in the highest tertile of 2-OHE1 to 16 alpha-OHE1 ratio (OR 0.56, 95% CI 0.19-1.68). The pooled estimates confirmed the association between an increased Pca risk and higher urinary levels of 16 alpha-OHE1 (third vs. first tertile: OR 1.82, 95% CI 1.09-3.05) and the protective effect of a higher 2-OHE 1 to 16 alpha-OHE1 ratio (third vs. first tertile: OR 0.53, 95% CI 0.31-0.90). Conclusion: Our study and the pooled results provide evidence for a differential role of the estrogen hydroxylation pathway in Pca development and encourage further study.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis
    Maddalena Barba
    Li Yang
    Holger J Schünemann
    Francesca Sperati
    Sara Grioni
    Saverio Stranges
    Kim C Westerlind
    Giovanni Blandino
    Michele Gallucci
    Rossella Lauria
    Luca Malorni
    Paola Muti
    [J]. Journal of Experimental & Clinical Cancer Research, 28
  • [2] Urinary estrogens and prostate cancer: A case-control study and meta-analysis
    Barba, Maddalena
    Yang, Li
    Schunemann, Holger
    Sperati, Francesca
    Grioni, Sara
    Stranges, Saverio
    Westerlind, Kim
    Blandino, Giovanni
    Gallucci, Michele
    Lauria, Rossella
    Malorni, Luca
    Muti, Paola
    [J]. CANCER RESEARCH, 2009, 69
  • [3] Urinary estrogen metabolites and prostate cancer:: a case-control study in the United States
    Muti, P
    Westerlind, K
    Wu, TJ
    Grimaldi, T
    De Berry, J
    Schünemann, H
    Freudenheim, JL
    Hill, H
    Carruba, G
    Bradlow, L
    [J]. CANCER CAUSES & CONTROL, 2002, 13 (10) : 947 - 955
  • [4] Urinary estrogen metabolites and breast cancer: A case-control study
    Kabat, GC
    Chang, CJ
    Sparano, JA
    Sepkovic, DW
    Hu, XP
    Khalil, A
    Rosenblatt, R
    Bradlow, HL
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (07) : 505 - 509
  • [5] Urinary estrogen metabolites and breast cancer: A case-control study.
    Kabat, GC
    Chang, CJ
    Sparano, JA
    Sepkovic, DV
    Hu, XP
    Khalil, A
    Rosenblatt, R
    Bradlow, HL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (11) : 207 - 207
  • [6] Urinary estrogen metabolites and prostate cancer: a case–control study in the United States
    Paola Muti
    Kim Westerlind
    Tiejian Wu
    Thomas Grimaldi
    John De Berry
    Holger Schünemann
    Jo L. Freudenheim
    Helyn Hill
    Giuseppe Carruba
    Leon Bradlow
    [J]. Cancer Causes & Control, 2002, 13 : 947 - 955
  • [7] Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis
    Mahmoud, Abeer M.
    Al-Alem, Umaima
    Dabbous, Firas
    Ali, Mohamed M.
    Batai, Ken
    Shah, Ebony
    Kittles, Rick A.
    [J]. PLOS ONE, 2016, 11 (11):
  • [8] Cholelithiasis increased prostate cancer risk: evidence from a case-control study and a meta-analysis
    Li, Ya-Dong
    Ren, Zheng-Ju
    Gao, Liang
    Ma, Jun-Hao
    Gou, Yuan-Qing
    Tan, Wei
    Liu, Chuan
    [J]. BMC UROLOGY, 2022, 22 (01)
  • [9] Height and prostate cancer risk: A large nested case-control study (ProtecT) and meta-analysis
    Zuccolo, Luisa
    Harris, Ross
    Gunnell, David
    Oliver, Steven
    Lane, Jane Athene
    Davis, Michael
    Donovan, Jenny
    Neal, David
    Hamdy, Freddie
    Beynon, Rebecca
    Savovic, Jelena
    Martin, Richard Michael
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (09) : 2325 - 2336
  • [10] Urinary estrogen metabolites and prostate cancer risk: A case control analysis using healthy and biopsy controls
    Kosti, Ourania
    Goldman, Lenka
    Bebu, Lonut
    Hsing, Ann
    Collins, Sean
    Dritschilo, Anatoly
    Lynch, John
    Xu, Xia
    Veenstra, Timothy
    Goldman, Radoslav
    [J]. CANCER RESEARCH, 2010, 70